Menu Close

Athersys’ MultiStem Cell Therapy for Ischemic Stroke to Be Studied in MASTERS-2

July 31, 2018—Athersys, Inc. announced that the first patient has been enrolled in its phase 3 MASTERS-2 study evaluating the administration of the company’s MultiStem cell therapy for stroke treatment and enhanced recovery. The randomized, double-blind … (본문 전체 8/3/2018 4:58 AM)